NCT01314898 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers


Sponsors: Pfizer	Phases: Phase I
Indications	Acronym:
Healthy Volunteers
Age Groups: Adult	Gender: Both
Names: Drug: 3 mg PF-03882845 Drug: 10 mg PF-03882845 Drug: 30 mg PF-03882845 Drug: 100 mg PF-03882845 Drug: Spironolactone	Enrollment: 12

Additional information about NCT01314898.